Lantern Pharma Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.33
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.48
|
-0.21
|
0.27
|
56.25%
|
|
2022-06-30
|
-0.52
|
-0.41
|
0.11
|
21.15%
|
|
2022-03-31
|
-0.29
|
-0.38
|
-0.09
|
-31.03%
|
|
2021-12-31
|
-0.40
|
-0.32
|
0.08
|
20.00%
|
|
2021-09-30
|
-0.27
|
-0.36
|
-0.09
|
-33.33%
|
|
2021-06-30
|
-0.26
|
-0.21
|
0.05
|
19.23%
|
|
2021-03-31
|
-0.27
|
-0.24
|
0.03
|
11.11%
|
|
2020-12-31
|
-0.45
|
-0.47
|
-0.02
|
-4.44%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.00
|
|
2021-12-31
|
-1.13
|
|
2020-12-31
|
-1.45
|